Medical Device Daily Perspectives

A City of Two Tales

November 27, 2011 – 10:12 PM | By Mark McCarty | No comments yet

Forgive me for ripping off Dickens, but a good headline is priceless. This posting, however, is about two tales of an agency (located near Washington) with which we are all familiar.

The G18

November 23, 2011 – 7:50 AM | By Amanda Pedersen | No comments yet

[caption id="attachment_1118" align="alignleft" width="133" caption="Kris Shah, VP - Technical Division Manager, Baylis Medical, discusses one of the companys solutions, with the help of a skeleton model."][/caption]

Why Canada?

November 22, 2011 – 4:40 PM | By Amanda Pedersen | No comments yet

Earlier this year GE Healthcare established its first global Pathology Imaging Centre of Excellence (PICE) in Toronto, Ontario.

Canada knows innovation

November 21, 2011 – 5:39 PM | By Amanda Pedersen | 1 comment

[caption id="attachment_1104" align="alignleft" width="220" caption="Flag of Ontario"][/caption]

O Canada Eh!

November 17, 2011 – 5:23 PM | By Amanda Pedersen | No comments yet

[caption id="attachment_1094" align="alignleft" width="300" caption="Canadian flag"][/caption]

The Hit and the Pendulum; FDA, politics and medical devices

November 16, 2011 – 8:00 AM | By Mark McCarty | No comments yet

Keeping up, staying connected

November 11, 2011 – 4:03 PM | By Amanda Pedersen | 1 comment

Recently I posted a blog here about my observations of the medical device space over the last five years and how it has changed during my five-year tenure at Medical Device Daily. Like the industry, we too have changed a great deal since I joined the MDD staff in October 2006.

Being there first: Personalized medicine and the investor

November 10, 2011 – 8:05 PM | By Mark McCarty | No comments yet

[caption id="attachment_1071" align="alignleft" width="296" caption="Being there first: Who can resist it? Who can afford it?"][/caption]

Medtronic plans to enter ED market

November 4, 2011 – 3:33 PM | By Omar Ford | No comments yet

Medtronic has the potential to be a trend setter with its attempt to have drug eluting stents (DES) treat erectile dysfunction (ED).